These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 31420050)

  • 21. Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.
    Irani J; Salomon L; Oba R; Bouchard P; Mottet N
    Lancet Oncol; 2010 Feb; 11(2):147-54. PubMed ID: 19963436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial.
    Tice JA; Ettinger B; Ensrud K; Wallace R; Blackwell T; Cummings SR
    JAMA; 2003 Jul; 290(2):207-14. PubMed ID: 12851275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial.
    Pinkerton JV; Utian WH; Constantine GD; Olivier S; Pickar JH
    Menopause; 2009; 16(6):1116-24. PubMed ID: 19546826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, double-blind, controlled trial of a Chinese herbal formula (Er-Xian decoction) for menopausal symptoms in Hong Kong perimenopausal women.
    Zhong LL; Tong Y; Tang GW; Zhang ZJ; Choi WK; Cheng KL; Sze SC; Wai K; Liu Q; Yu BX
    Menopause; 2013 Jul; 20(7):767-76. PubMed ID: 23793167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hot flush frequency and severity at baseline as predictors of time to transient and stable treatment success: pooled analysis of two CE/BZA studies.
    Pinkerton JV; Bushmakin AG; Bobula J; Lavenberg J; Komm BS; Abraham L
    Menopause; 2017 Dec; 24(12):1378-1385. PubMed ID: 28654628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A natural S-equol supplement alleviates hot flushes and other menopausal symptoms in equol nonproducing postmenopausal Japanese women.
    Aso T; Uchiyama S; Matsumura Y; Taguchi M; Nozaki M; Takamatsu K; Ishizuka B; Kubota T; Mizunuma H; Ohta H
    J Womens Health (Larchmt); 2012 Jan; 21(1):92-100. PubMed ID: 21992596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, double-blind, placebo-controlled study of the effect of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) on menopausal symptoms in Hong Kong Chinese women.
    Haines CJ; Lam PM; Chung TK; Cheng KF; Leung PC
    Climacteric; 2008 Jun; 11(3):244-51. PubMed ID: 18568789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phytoestrogens for treatment of menopausal symptoms: a systematic review.
    Krebs EE; Ensrud KE; MacDonald R; Wilt TJ
    Obstet Gynecol; 2004 Oct; 104(4):824-36. PubMed ID: 15458907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial.
    Pinkerton JV; Constantine G; Hwang E; Cheng RF;
    Menopause; 2013 Jan; 20(1):28-37. PubMed ID: 23010882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo.
    van de Weijer PH; Barentsen R
    Maturitas; 2002 Jul; 42(3):187-93. PubMed ID: 12161042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acupuncture for hot flushes in perimenopausal and postmenopausal women: a randomised, sham-controlled trial.
    Kim DI; Jeong JC; Kim KH; Rho JJ; Choi MS; Yoon SH; Choi SM; Kang KW; Ahn HY; Lee MS
    Acupunct Med; 2011 Dec; 29(4):249-56. PubMed ID: 21653660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms.
    Bouchard P; Panay N; de Villiers TJ; Vincendon P; Bao W; Cheng RJ; Constantine G
    Climacteric; 2012 Feb; 15(1):12-20. PubMed ID: 22066790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of micronutrient supplementation on vasomotor symptoms in postmenopausal women.
    Andrikoula M; Baker D; Nesic J; Liao LM; Duka T; Prelevic GM
    Climacteric; 2011 Oct; 14(5):544-50. PubMed ID: 21413865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of hot flushes in postmenopausal women who receive raloxifene therapy.
    Aldrighi JM; Quail DC; Levy-Frebault J; Aguas F; Kosian K; Garrido L; Bosio-Le Goux B; Saráchaga M; Graebe A; Niño AJ; Nickelsen T
    Am J Obstet Gynecol; 2004 Dec; 191(6):1979-88. PubMed ID: 15592280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Chlorogenic Acids on Menopausal Symptoms in Healthy Women: A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Trial.
    Enokuchi Y; Suzuki A; Yamaguchi T; Ochiai R; Terauchi M; Kataoka K
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33297409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a standardized soy extract on hot flushes: a multicenter, double-blind, randomized, placebo-controlled study.
    Faure ED; Chantre P; Mares P
    Menopause; 2002; 9(5):329-34. PubMed ID: 12218721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: a double-blind, randomized, placebo-controlled trial of efficacy and safety.
    Archer DF; Dupont CM; Constantine GD; Pickar JH; Olivier S;
    Am J Obstet Gynecol; 2009 Mar; 200(3):238.e1-238.e10. PubMed ID: 19167693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial.
    Evans ML; Pritts E; Vittinghoff E; McClish K; Morgan KS; Jaffe RB
    Obstet Gynecol; 2005 Jan; 105(1):161-6. PubMed ID: 15625158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance training for hot flushes in postmenopausal women: Randomized controlled trial protocol.
    Berin E; Hammar ML; Lindblom H; Lindh-Åstrand L; Spetz Holm AC
    Maturitas; 2016 Mar; 85():96-103. PubMed ID: 26857887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose estradiol spray to treat vasomotor symptoms: a randomized controlled trial.
    Buster JE; Koltun WD; Pascual ML; Day WW; Peterson C
    Obstet Gynecol; 2008 Jun; 111(6):1343-51. PubMed ID: 18515518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.